Komori
Sundrug (9989) · RiskRestated

Dependence on management and staffing shortages during organisational expansion

First written in FY2017. 14 of 16 entries say "Restated". Latest entry: FY2027-H1.

16entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2020-Q1RestatedFY2022-Q1 – FY2027-H12017: 120172018: 320182019: 320192020: 020202021: 320212022: 220222023: 120232024: 220242025: 020252026: 12026
Same theme, other companies
Management dependence and personnel shortages during organisational expansionA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It was stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  2. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the interim consolidated accounting period. In addition, there were no significant changes to the business and other risks described in the previous fiscal year's Annual Securities Report.」

    It was stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  3. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  4. FY2023RestatedAnnual report

    「The management team, including the representative director, president and CEO, plays important roles in each business area. If these directors become unable to perform their duties, the Group's business performance could be affected.」

    The company continues to disclose the risk of dependence on management and identifies management development through training programs for directors and employee training as a response measure.
  5. FY2023-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  6. FY2022RestatedAnnual report

    「The management team, including the representative director, president and CEO, plays important roles in each business area. If these directors become unable to perform their duties, the Group's business performance could be affected.」

    The company continues to disclose the risk of dependence on management and identifies management development through training programs for directors and employee training as a response measure.
  7. FY2022-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It was stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  8. FY2022-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It was stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  9. FY2021MitigatedAnnual report

    「The Group is promoting the development of its management team through in-house and external training, including executive training for directors and department-head-level personnel, as well as level-based and job-specific training and executive examinations. It has also begun providing e-learning through the Listed Company Governance Course to all directors and senior employees, further advancing management development.」

    The company described measures addressing dependence on management and the shortage of successor personnel through executive training, executive examinations and e-learning via the Listed Company Governance Course.
  10. FY2020-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  11. FY2019RestatedAnnual report

    「The management team, including the representative director, plays important roles in each business area. If these directors become unable to perform their duties, the Group's business performance could be affected.」

    The risks associated with dependence on management and the impact on business performance if directors become unable to perform their duties remain unchanged.
  12. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  13. FY2019-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  14. FY2018RestatedAnnual report

    「The management team, including the representative director, plays important roles in each business area. If these directors become unable to perform their duties, the Group's business performance could be affected.」

    The risks associated with dependence on management and the inability to secure and train personnel in line with market expansion continue to be disclosed as organisational risks.
  15. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    It stated that there have been no material changes in the risks associated with dependence on management and staffing shortages during organisational expansion.
  16. FY2017First statedAnnual report

    「The management team, including the representative director, plays important roles in each business area. If these directors become unable to perform their duties, the Group's business performance could be affected.」

    The company recorded the risk of management becoming unable to perform its duties and the risk of being unable to secure sufficient personnel to support market expansion as risks to its business structure.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.